/
/
Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
This content is Free Access.
Capítulos
- 00:05Introduction
- 00:27Antibody-Mediated Activation of NK Cells
- 03:12Interrogation of Signaling Molecules by Western Blot Analysis
- 03:47Isolation of mRNA and Preparation for Chemokine/Cytokine Assessment
- 04:39Cytoskeletal Rearrangement Assessment
- 05:57Assessing Degranulation Using CD107a Surface Staining
- 07:10Results: Downstream Applications of NK Cell Activation Assay
- 09:20Conclusion
A protocol for studying FcγRIIIa-driven events by therapeutic antibodies in human natural killer cells is described here. This artificial stimulation platform permits the interrogation of downstream effector functions such as degranulation, chemokine/cytokine production, and signaling pathways mediated by the FcγRIIIa and Fc portions of antibodies involved in binding.
